Quarterly report · Q2
6960.TEDINET S100PJZR
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥132.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥11.1bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥10.4bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥11.7bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.7bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥11.8bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥11.0bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥16.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥7.5bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥196.9bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥195.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥183.1bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥41.7bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥45.6bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥155.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥149.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥142.9bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥66.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥64.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥63.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥61.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥52.5bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥536.85 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥348.31 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,072.38 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥495.61 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥312.3 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥17.1bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥17.1bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥26.9bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥26.9bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥5.2bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥5.2bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥881m |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥62.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥62.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥11.1bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥16.2bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥16.2bn |
| jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥2.2bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥27.0bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥27.0bn |
| jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥5.5bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥6.2bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥6.2bn |
| jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥12.3bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥12.3bn |
| jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥61.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥61.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥10.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 528
| Item | Context | Value | Unit |
|---|---|---|---|
| Work in process | Prior1YearInstant | 205000000 | JPY |
| Work in process | CurrentQuarterInstant | 323000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 3940000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 5091000000 | JPY |
| Other ca | Prior1YearInstant | 2217000000 | JPY |
| Other ca | CurrentQuarterInstant | 1579000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -23000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -5000000 | JPY |
| Current assets | Prior1YearInstant | 119736000000 | JPY |
| Current assets | CurrentQuarterInstant | 119066000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 45264000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 46184000000 | JPY |
| Intangible assets | Prior1YearInstant | 1538000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 1519000000 | JPY |
| Investment securities | Prior1YearInstant | 9671000000 | JPY |
| Investment securities | CurrentQuarterInstant | 10693000000 | JPY |
| Other ioa | Prior1YearInstant | 19293000000 | JPY |
| Other ioa | CurrentQuarterInstant | 19411000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -8000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -11000000 | JPY |
| Investments and other assets | Prior1YearInstant | 28956000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 30093000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 75759000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 77797000000 | JPY |
| Assets | Prior1YearInstant | 195495000000 | JPY |
| Assets | CurrentQuarterInstant | 196864000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 15501000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 14455000000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 6648000000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 6090000000 | JPY |
| Short term loans payable | Prior1YearInstant | 1750000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 1800000000 | JPY |
| Income taxes payable | Prior1YearInstant | 3451000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 2526000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 3439000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 2909000000 | JPY |
| Provision for product warranties | Prior1YearInstant | 117000000 | JPY |
| Provision for product warranties | CurrentQuarterInstant | 133000000 | JPY |
| Other provision cl | Prior1YearInstant | 579000000 | JPY |
| Other provision cl | CurrentQuarterInstant | 212000000 | JPY |
| Other cl | Prior1YearInstant | 7339000000 | JPY |
| Other cl | CurrentQuarterInstant | 6879000000 | JPY |
| Current liabilities | Prior1YearInstant | 38829000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 35007000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 3137000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 3179000000 | JPY |
| Other provision ncl | Prior1YearInstant | 752000000 | JPY |
| Other provision ncl | CurrentQuarterInstant | 658000000 | JPY |
| Other ncl | Prior1YearInstant | 2918000000 | JPY |
| Other ncl | CurrentQuarterInstant | 2878000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |